Independence & Conflict of Interest Policy

How BCI Lab enforces independence from the entities it evaluates, stated plainly, including what is still being built.

Summary of Changes (v1.1 → v1.2)

• Retired the entity name “BCI Structural Dynamics Lab” throughout, in favor of BCI Lab, the sole current entity name (§I)
• Corrected the claim that a Governance Committee holds final publication authority; that authority currently rests with the Founding Partner, pending the Committee's formation (§III, §VIII)
• Added a personal conflict-of-interest standard for individual analysts, disclosed as being built rather than already formalized (§II, new)
• Disclosed BCI Lab's practice of ad hoc consultation with outside practitioners and academic researchers for factual accuracy, and distinguished it explicitly from governance authority (§VIII)
• Removed a reference to confidence-interval outputs, consistent with the retirement of the confidence-band mechanism at BSIP v4.0 §9.6 (§V)
• Replaced legacy terminology (“configuration state,” “Configuration-Risk Analysis”) with current BSIP v4.0 language (§VII, §X)
• Clarified that core variable definitions and the master formula are published openly for citation; only the weighting architecture and scoring coefficients are proprietary (§XI)
• Added a Jurisdiction clause, consistent with BCI Lab's other governing documents (§XII, new)

This document sets out BCI Lab's independence commitments and the safeguards that enforce them. Where this document and any other BCI Lab publication describe the same commitment differently, this document governs.

BCI Lab operates as an independent research institution. It is not a registered investment adviser, a credit rating agency, a broker-dealer, a marketing consultancy, or a public relations entity.

BCI Lab does not accept equity participation, revenue-sharing arrangements, success-based compensation, contingent fees, or any other performance-linked compensation from an entity subject to its structural diagnostics. BCI Lab holds no equity or derivative exposure in any entity it evaluates. No compensation is linked to a valuation outcome, a capital raise, stock performance, or the reputational consequence of a published finding.

BCI Lab's sole commercial model is subscription-based or fixed-fee institutional research access, purchased by parties on the buy side of a transaction or governance decision: private equity and strategic acquirers during diligence, institutional subscribers, and credit and risk analysts. This is not a policy under periodic reconsideration; changing it would require a public amendment to this document, recorded in the Methodology Version Register.

Any commercial engagement with a covered entity is disclosed internally and reviewed under the arrangements set out in Section VIII.

BCI Lab is building toward a personal conflict-of-interest standard governing individual analysts: a prohibition on holding a financial position in a covered entity while an engagement on it is active, and a recusal requirement where an analyst has a pre-existing personal or professional relationship with a covered entity.

That standard has not yet been formalized into a standing policy. This document states that plainly rather than assert a control that does not yet exist in written form. Until it is formalized, a determination of this kind is made directly by BCI Lab's Founding Partner on a case-by-case basis, and each instance is retained under the audit-log standard set out in Section V.

A covered entity may be invited to verify factual accuracy: financial data, public disclosures, and operational facts. A covered entity may not use that review to influence variable weighting, request alteration of a model output, negotiate a structural conclusion, or condition the timing of publication on reputational concern.

A draft report is not subject to narrative negotiation. Language may be clarified for factual precision. It is not softened for reputational accommodation.

Final authority over the timing, structure, and content of a published reading currently rests with BCI Lab's Founding Partner, pending the formation of the Governance Committee described in Section VIII.

BCI Lab does not suppress a structural finding because of commercial pressure, reputational sensitivity, or a client relationship. Model parameters are applied consistently across entities within the same category classification, and any sector-specific calibration adjustment is disclosed under the Sector-Specific Calibration Governance Protocol before it is used in a published reading.

Every report discloses its data cut-off date, the protocol version under which it was produced, and a revision-log identifier. A post-publication revision requires a documented rationale and a corresponding version update, recorded in the Methodology Version Register.

All analytical inputs, model outputs, calibration logs, and published diagnostics are retained for a minimum of three years from the date of publication, to support independent verification and internal audit. Retained materials include data-extraction timestamps, sampling summaries, model parameter configurations, per-variable data-reliability grades, and revision records.

Retained materials are stored with controlled access. Modification of an archived record requires logged authorization, and deletion before the retention period expires is prohibited absent a legal obligation to do so.

A covered entity may submit a written response within fourteen business days of a report's publication. A response may address a factual inaccuracy or a publicly verifiable data discrepancy. A response may not challenge the model's structure, a variable's definition, or the calibration logic behind a weighting.

Where BCI Lab judges a response warranted, it is published as an addendum noting that a formal response exists. BCI Lab retains sole discretion over the addendum's format and placement, and a response does not retroactively alter the original reading.

BCI Lab's outputs are structural diagnostic observations, issued under the Category A, B, or C taxonomy set out in the BCI Structural Integrity Protocol. They do not constitute a credit rating, a fairness opinion, an investment recommendation, legal advice, or an accounting determination, and they are not a source of investment-return forecasts. BCI Lab assumes no fiduciary responsibility for a decision made in response to its publications, and no structural reading constitutes an evaluation of any management team's competence, motive, or compliance.

Methodological changes and independence-safeguard determinations currently rest with BCI Lab's Founding Partner. BCI Lab is building toward an independent, multi-member Governance Committee with standing authority to review conflict-of-interest determinations, approve material calibration changes, and investigate a suspected breach of independence, without requiring the Founding Partner's sign-off.

That committee has not yet been formed. This document states that plainly rather than describe a body that does not yet exist. Until it is seated, a suspected breach of independence, a data-integrity concern, or an allegation of publication interference is reviewed directly by the Founding Partner, and the outcome of that review is retained under the same audit-log standard set out in Section V.

Separately from that governance function, BCI Lab may consult a practitioner with direct, ongoing experience inside a covered sector, or an academic researcher with relevant subject-matter expertise, on an ad hoc basis, to check the factual and contextual accuracy of a specific analysis before it is published. This consultation is advisory only. It informs BCI Lab's own independent judgment; it carries no authority over a reading's conclusions, tier, or methodology, and it is not a substitute for the Governance Committee described above. Where a consulted practitioner has a current or recent affiliation with the entity under analysis, that relationship is disclosed internally and handled with the same confidentiality standard applied to any other source.

This Policy is reviewed whenever a material governance gap is identified, and in full at each material revision to the BCI Structural Integrity Protocol. The formation, membership, and first review cycle of the Governance Committee, and the eventual formalization of the personal conflict-of-interest standard described in Section II, are each recorded in the public Methodology Version Register at the point they become real, not announced in advance of being true.

BCI Lab does not accept an engagement whose evident purpose is to produce a negative reading of a competitor, a litigation target, or an activist campaign subject, rather than an independent structural assessment. Where an engagement's framing suggests the client has predetermined the conclusion it is seeking, BCI Lab declines the engagement rather than proceed and disclose the conflict afterward.

BCI Lab prohibits the use of its published research for market manipulation, a coordinated reputational attack, or selective quotation built to support a misleading narrative, and reserves the right to issue a clarifying statement where its findings are materially misrepresented.

A structural reading reflects the asset's structural state as of its data cut-off date. A subsequent macroeconomic shock, regulatory change, or comparable external event can alter that state without triggering an immediate revision.

The absence of a near-term financial consequence does not invalidate a structural observation. Structural deterioration and its financial confirmation are frequently separated by a real interval, documented case by case in BCI Lab's backtest registry; a reading is not wrong merely because the market has not yet caught up to it.

The core variable definitions, the master formula, and the dimensional framework underlying BCI Lab's diagnostics are published openly, in the BCI Structural Integrity Protocol, the White Paper, and the BCI Lexicon, and are made available for reference and citation. What remains proprietary is the specific weighting architecture, internal scoring coefficients, and calibration data behind an individual reading. Unauthorized commercial replication of BCI Lab's scoring engine, or reverse engineering undertaken to reproduce it for a competing commercial service, is prohibited.

This Policy, and BCI Lab's frameworks and reports generally, are governed exclusively by the laws of the Hong Kong Special Administrative Region.

This Policy is amended only through the version-controlled process that governs the BCI Structural Integrity Protocol. A material change to a commitment in this document is documented, dated, and preserved in the Methodology Version Register alongside the version it supersedes. No prior commitment is quietly dropped.